Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 53, 2018 - Issue 12
Submit an article Journal homepage
292
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of noninvasive markers for the diagnosis of cystic fibrosis liver disease

Alexandra Alexopoulou2nd Department of Internal Medicine and Research Laboratory, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece; Correspondence[email protected]
,
Sophia Pouriki2nd Department of Internal Medicine and Research Laboratory, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece;
,
Larisa Vasilieva2nd Department of Internal Medicine and Research Laboratory, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece;
,
Theodoros Alexopoulos2nd Department of Internal Medicine and Research Laboratory, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece;
,
Vasiliki FiladitakiThird Respiratory Medicine Department, Sismanogleio General Hospital, Athens, Greece
,
Maria GiokaThird Respiratory Medicine Department, Sismanogleio General Hospital, Athens, Greece
,
Filia DiamanteaThird Respiratory Medicine Department, Sismanogleio General Hospital, Athens, Greece
&
Spyros P. Dourakis2nd Department of Internal Medicine and Research Laboratory, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece;
show all
Pages 1547-1552 | Received 19 Aug 2018, Accepted 06 Oct 2018, Published online: 02 Jan 2019

References

  • Elborn JS. Cystic fibrosis. Lancet. 2016;388:2519–2531.
  • Castellani C, Cuppens H, Macek M, Jr, et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros. 2008;7:179–196.
  • Sosnay PR, Siklosi KR, Van Goor F, et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet. 2013;45:1160–1167.
  • Burgel PR, Bellis G, Olesen HV, et al. ERS/ECFS task force on provision of care for adults with cystic Fibrosis in Europe. Future trends in cystic fibrosis demography in 34 European countries. Eur Respir J. 2015;46:133–141.
  • Cohen-Cymberknoh M, Shoseyov D, Kerem E. Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. Am J Respir Crit Care Med. 2011;183:1463–1471.
  • Wainwright CE, Elborn JS, Ramsey BW. Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR. N Engl J Med. 2015;29:1783–1784.
  • Colombo C. Liver disease in cystic fibrosis. Curr Opin Pulm Med. 2007;13:529–536.
  • Lindblad A, Glaumann H, Strandvik B. Natural history of liver disease in cystic fibrosis. Hepatology. 1999;30:1151–1158.
  • Spengler EK, Loomba R. Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Mayo Clin Proc. 2015;90:1233–1246.
  • Lewindon PJ, Shepherd RW, Walsh MJ, et al. Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy. Hepatology. 2011;53:193–201.
  • Debray D, Kelly D, Houwen R, et al. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros. 2011;10:S29–S36.
  • Koh C, Sakiani S, Surana P, et al. Adult-onset cystic fibrosis liver disease: diagnosis and characterization of an underappreciated entity. Hepatology. 2017;66:591–601.
  • Smyth AR, Bell SC, Bojcin S, et al. European cystic fibrosis society. European cystic fibrosis society standards of care: best practice guidelines. J Cyst Fibros. 2014;13:S23–S42.
  • Colombo C, Battezzati PM, Crosignani A, et al. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology. 2002;36:1374–1382.
  • Parisi GF, Di Dio G, Franzonello C, et al. Liver disease in cystic fibrosis: an update. Hepat Mon. 2013;13:e11215.
  • Chryssostalis A, Hubert D, Coste J, et al. Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation. J Hepatol. 2011;55:1377–1382.
  • Menten R, Leonard A, Clapuyt P, et al. Transient elastography in patients with cystic fibrosis. Pediatr Radiol. 2010;40:1231–1235.
  • Witters P, De Boeck K, Dupont L, et al. Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease. J Cyst Fibros. 2009;8:392–399.
  • Leung DH, Khan M, Minard CG, et al. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease. Hepatology. 2015;62:1576–1583.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.